Larvol Delta - Biosyngen39s-BST02-the-World39s-First-TIL-Therapy-for-Liver-Cancer-is-Granted-an-IND-Approval-by-FDA

BST02 - Biosyngen

https://www.prnewswire.com/news-releases/biosyngens-bst02-the-worlds-first-til-therapy-for-liver-cancer-is-granted-an-ind-approval-by-fda-301968656.html

Oct 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next